Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimicrobial Effectiveness of ZuraPrep
NCT03782103Phase 3Completed
- Sponsor
- Zurex Pharma
- Start
- Jan 2019
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ChloraPrep in surgical site infection (SSI) (3 arms), sponsored by Zurex Pharma. Primary endpoints: Bacterial Reduction - Groin and Bacterial Reduction - Abdomen. Started Jan 2019; status: completed.
02
Drugs
ChloraPrep
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03782103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03782103.